500 patients67,039 observations150 daysLIVE
← Patients

Patient P-03484

Synthetic patientONX-7 · Day 145 · 75+ · F · baseline S07Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Deteriorating
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
32%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 started — Baseline state S07
  2. Day 15 Trajectory diverged from prediction — Observed response fell below the model's expected path.
  3. Day 18 DT-01 recommended — Dosing / Timing Recommendation DT-01
  4. Day 19 Patient accepted — Started DT-01 in the companion
  5. Day 24 GI symptom burden −19% vs expected — Dosing / Timing Recommendation DT-01
  6. Day 30 Tolerance state changed — Unstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 15.

Primary contributors, last 14 days
  • Nutritional resilience-15
  • Inflammatory activity+13
  • Toxicity+12
  • GI instability+9

What helped?

  • Dosing / Timing Recommendation DT-01Day 18
    Result: symptom burden −19%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Energy level
Daily log
5.4/10
worsening · -0.7 vs previous 14 d
Stress level
Daily log
4.5/10
worsening · +0.7 vs previous 14 d
Pessimism score
Daily log
4.1/10
worsening · +0.3 vs previous 14 d
Sleep quality
Wearable
30.1/100
worsening · -3.1 vs previous 14 d
Libido
Daily log
4/10
worsening · -0.6 vs previous 14 d
HRV
Wearable
32.1 ms
worsening · -3.7 vs previous 14 d
Toxicity
Blood
23.4/100
worsening · +7.5 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards failing · 55 from the failing basin, 34 from restoration.

Would help
  • No untried action with strong evidence. Compose one from primitives.
  • More protein
    GI -2.8 next day on high-intake days · n 22
Would not help
  • AD-05 Adherence Support
    only 21% improved among 14 similar
  • Keep fat low
    GI +2.2 next day on high-intake days · n 23
  • Keep histamine low
    GI +2 next day on high-intake days · n 17
  • Keep lactose low
    GI +1.8 next day on high-intake days · n 22
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Protein
    -2.8supporter · 95%
  • Dietary fat load
    +2.2detractor · 85%
  • Histamine load
    +2detractor · 66%
  • Lactose
    +1.8detractor · 66%
  • Alcohol
    -0.9no signal · 26%
  • Caffeine
    -0.8no signal · 31%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Butyrate / short-chain fatty acid production ↓60
    • MicrobiomeButyrate capacity 24/100
    • MicrobiomeF. prausnitzii depleted
  • Autonomic recovery ↓45
    • WearableResting HR 78 bpm
    • WearableShort sleep window
  • Inflammatory signalling ↑35
    • MicrobiomeBacteroides fragilis expansion
    • WearableHRV 32 ms, trending down
  • Drug metabolism and exposure ↑35
    • DNADPYD *2A → slower clearance
  • Mucosal barrier integrity ↓30
    • DNAFUT2 non-secretor lowers mucosal fucosylation
DNA
Fictional pharmacogenomic panel
  • FUT2 rs601338 AA (non-secretor)
    Reduced mucosal fucosylation
  • DPYD *2A heterozygous
    Slower drug clearance
  • CYP2D6 Normal metabolizer
    Expected exposure
Microbiome
Shannon diversity 3 · butyrate capacity 24/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisHigh
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
28 ms
Sleep
5.8 h
Steps
6,414
Resting HR
76 bpm
Daily log: GI score 32, nutritional resilience 53, adherence 96.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Log the daily check-in; one line is enough
  • Keep the current walking rhythm
  • Protect a 7.5-hour sleep window; screens off 30 minutes before
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
PatientSimilarityBaselineInterventionOutcomeResponse today
P-0319852%S11——52
P-0342050%S08——59
P-0338949%S01——50
P-0325548%S01HY-01improved53
P-0347148%S08——54
P-0317946%S05GI-04improved52
P-0310245%S19——35
P-0314445%S16HY-01improved52
P-0317244%S17DT-01no change48
P-0337244%S19——53
P-0321943%S17——49
P-0306442%S10——50